Diaceutics PLC
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DIUXF research report →
Companywww.diaceutics.com
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks.
- CEO
- Ryan Keeling
- IPO
- 2020
- Employees
- 184
- HQ
- Belfast, GB
Price Chart
Valuation
- Market Cap
- $141.33M
- P/E
- -46.86
- P/S
- 4.15
- P/B
- 1.91
- EV/EBITDA
- 49.50
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 86.12%
- Op Margin
- -6.45%
- Net Margin
- -4.42%
- ROE
- -3.94%
- ROIC
- -5.13%
Growth & Income
- Revenue
- $32.16M · 35.69%
- Net Income
- $-1,703,000 · 2.46%
- EPS
- $-0.02 · 2.42%
- Op Income
- $-2,455,000
- FCF YoY
- -12.33%
Performance & Tape
- 52W High
- $2.51
- 52W Low
- $1.37
- 50D MA
- $1.67
- 200D MA
- $1.50
- Beta
- 0.92
- Avg Volume
- 8.16K
Get TickerSpark's AI analysis on DIUXF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DIUXF Coverage
We haven't published any research on DIUXF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DIUXF Report →